1 / 6

Post- discharge is a vulnerable phase for heart failure patients

Post- discharge is a vulnerable phase for heart failure patients. “Hospitalized heart failure is associated with unacceptable high post-discharge mortality and rehospitalization rate ” 1.

gwidon
Download Presentation

Post- discharge is a vulnerable phase for heart failure patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Post-dischargeis a vulnerable phase for heartfailure patients

  2. “Hospitalized heart failure is associated with unacceptable high post-discharge mortality and rehospitalization rate”1 • Several recent publications1-5 discuss important issues on hospitalized heart failure patients who have unacceptably high post-discharge mortality and rehospitalization rates. A high event rate despite all available therapies makes this topic a health care priority in terms of patient well-being and expenditure. • With the aging of the population and an ever-increasing burden of disease, the cumulative incidence and prevalence of heart failure requiring hospitalization have evolved into epidemic proportions. The costs associated with hospitalized heart failure have added demands from society, government, and payers to improve outcomes. REFERENCES------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 1-Gheorghiade M, Shah AN, Vaduganathan M, et al. Recognizinghospitalizedheartfailure as an entity and developing new therapies to improveoutcomesacademics’, clinicians’, industry’s, regulators’, and payers’ perspectives. Heart Failure Clin. 2013;9:285-290. 2-Joynt KE, Jha AK. Who has higher readmission rates for heart failure, and why? Implications for efforts to improve care using financial incentives. CircCardiovascQual Outcomes. 2011;4:53-59. 3-Chun S, Tu JV, Wijeysundera HC, Austin PC, Wang X, Levy D, Lee DS. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail. May 2, 2012. doi 10.1161/ CIRCHEARTFAILURE.111.964791. http://circheartfailure.ahajournals.org. Accessed April 19, 2012. 4-Krumholz HM. Post-hospital syndrome – an acquired, transient condition of generalized risk. N Engl J Med. 2013;368;100-102. 5-Marti CN, Fonarow GC, Gheorghiade M, Butler J. Timing and  duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail. 2013;6:1095-1101.

  3. Mortalityisparticularly high in the early phase afterhospitalization All-cause mortalityafterdischarge for HF ishigh at the 1stmonth1 Changes in risk profile afterhospitalization. Hasard ratio of all-cause mortalityafterdischargefromhospital for first hospitalization for heartfailure ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 1-Marti NC, Fonarow GC, Gheorghiade M, Bulter J. Timing and  duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail 2013;6:1095-1101

  4. Rehospitalizationisparticularly high in the early phase after hospitalization1 30 daysfromdischarge 6 monthsfromdischarge 1patient out of 4isreadmitted1-2 1patient out of 2isreadmitted3-4 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ 1-Gheorghiade M, Shah AN, Vaduganathan M, et al. Recognizinghospitalizedheartfailure as an entity and developing new therapies to improveoutcomesacademics’, clinicians’, industry’s, regulators’, and payers’ perspectives. Heart Failure Clin. 2013;9:285-290. 2-Marti NC, Fonarow GC, Gheorghiade M, Butler J. Timing and  duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail. 2013;6:1095-1101. 3-Joynt KE, Jha AK. Who has higher readmission rates for heart failure, and why? Implications for efforts to improve care using financial incentives. CircCardiovascQual Outcomes. 2011;4:53-59. 4-Chun S, Tu JV, Wijeysundera HC, Austin PC, Wang X, Levy D, Lee DS. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail. May 2, 2012. doi 10.1161/ CIRCHEARTFAILURE.111.964791. http://circheartfailure.ahajournals.org. Accessed April 19, 2012.

  5. Weeks to months post-discharge at high risk may be viewed as a“vulnerable phase”1,2 • The post-discharge period is described as an “acquired, transient condition of generalized risk” or “a period of vulnerability”. 1 • Comprehensive strategies should focus on factors during hospitalization and also during the early recovery period soon after discharge to target stressors that probably contribute to the vulnerability of patients. 1,2 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------1-Krumholz HM. Post-hospital syndrome – an acquired, transient condition of generalized risk. N Engl J Med. 2013;368;100-102. 2-Marti NC, Fonarow GC, Gheorghiade M, Butler J. Timing and duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail. 2013;6:1095-1101.

  6. Initiating therapy during hospitalization is suggested to reduce the risk of adverse outcomes1-2 • Atdischarge, patients canbeconsidered to be in a stable chronicheartfailure state at high risk for adverse outcomes.1 -2 • “Initiating therapies in patients who are stabilized in the hospital and continued long-term provides a potent option to improve long-term clinical outcomes.”1 • “Delaying initiation of potentially effective therapies for weeks to months post discharge risks unabated high risk for adverse events in the meantime.”1 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------1-Gheorghiade M, Shah AN, Vaduganathan M, et al. Recognizinghospitalizedheartfailure as an entity and developing new therapies to improveoutcomesacademics’, clinicians’, industry’s, regulators’, and payers’ perspectives. Heart Failure Clin. 2013;9:285-290. 2-Marti NC, Fonarow GC, Gheorghiade M, Butler J. Timing and  duration of interventions in clinical trials for patients with hospitalized heart failure. Circ Heart Fail. 2013;6:1095-1101.

More Related